- Home
- PROP vs IRWD Comparison
PROP vs IRWD Comparison
Compare PROP & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROP
- IRWD
- Stock Information
- Founded
- PROP 2001
- IRWD 1998
- Country
- PROP United States
- IRWD United States
- Employees
- PROP N/A
- IRWD N/A
- Industry
- PROP Investment Bankers/Brokers/Service
- IRWD Biotechnology: Pharmaceutical Preparations
- Sector
- PROP Finance
- IRWD Health Care
- Exchange
- PROP Nasdaq
- IRWD Nasdaq
- Market Cap
- PROP 120.5M
- IRWD 111.2M
- IPO Year
- PROP N/A
- IRWD 2010
- Fundamental
- Price
- PROP $2.47
- IRWD $1.27
- Analyst Decision
- PROP Strong Buy
- IRWD Buy
- Analyst Count
- PROP 5
- IRWD 5
- Target Price
- PROP $8.50
- IRWD $4.94
- AVG Volume (30 Days)
- PROP 2.7M
- IRWD 1.6M
- Earning Date
- PROP 08-12-2025
- IRWD 08-07-2025
- Dividend Yield
- PROP N/A
- IRWD N/A
- EPS Growth
- PROP N/A
- IRWD N/A
- EPS
- PROP N/A
- IRWD N/A
- Revenue
- PROP $88,854,000.00
- IRWD $308,519,000.00
- Revenue This Year
- PROP $5,710.68
- IRWD N/A
- Revenue Next Year
- PROP $28.49
- IRWD N/A
- P/E Ratio
- PROP N/A
- IRWD N/A
- Revenue Growth
- PROP N/A
- IRWD N/A
- 52 Week Low
- PROP $2.01
- IRWD $0.53
- 52 Week High
- PROP $12.30
- IRWD $5.21
- Technical
- Relative Strength Index (RSI)
- PROP 38.82
- IRWD 71.88
- Support Level
- PROP $2.01
- IRWD $0.81
- Resistance Level
- PROP $2.83
- IRWD $1.16
- Average True Range (ATR)
- PROP 0.29
- IRWD 0.12
- MACD
- PROP -0.08
- IRWD 0.03
- Stochastic Oscillator
- PROP 26.44
- IRWD 83.94
About PROP Prairie Operating Co.
Prairie Operating Co is a Houston-based independent energy company engaged in the development and acquisition of oil and natural gas resources in the United States. The Company's assets and operations are concentrated in the oil and liquids-rich regions of the Denver-Julesburg (DJ) Basin, with a focus on the Niobrara and Codell formations. The Company is committed to the responsible development of its oil and natural gas resources and is focused on maximizing returns through consistent growth, capital discipline, and sustainable cash flow generation.
About IRWD Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.